Latest News

Add to Favorites Subscribe Share
newswise-fb-share-
  • Embargo expired:
    23-Jan-2020 5:00 AM EST

New drug target for prostate cancer found in the non-coding genome

University Health Network (UHN)

Scientists at Princess Margaret Cancer Centre have identified the drivers of a crucial gene involved in prostate cancer, revealing new targets for drug design. Researchers identified a set of cis-regulatory elements – namely enhancers and the promoter – in the non-coding region of the genome, which affect the expression of FOXA1 gene, one of the major drivers or oncogenes involved in prostate cancer development.

Channels: Cancer, Healthcare, Men's Health, Pharmaceuticals,

Released:
22-Jan-2020 5:55 PM EST
Open in New Tab
Comment
Newswise: Study finds many youth living with undiagnosed chronic fatigue syndrome
  • Embargo expired:
    23-Jan-2020 5:00 AM EST

Study finds many youth living with undiagnosed chronic fatigue syndrome

DePaul University

Most youth living with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) have not been diagnosed, according to a new prevalence study from researchers at DePaul University and Ann & Robert H. Lurie Children’s Hospital of Chicago, published by the journal Child & Youth Care Forum. Leonard A. Jason, a professor of psychology at DePaul University, led the seven-year study to screen more than 10,000 children and teenagers in the Chicago area.

Channels: Children's Health, Family and Parenting, Healthcare, Psychology and Psychiatry, All Journal News, Grant Funded News,

Released:
22-Jan-2020 3:45 PM EST
Open in New Tab
Comment
Research Results
Signature-Vertical.png

Study Uncovers Unexpected Connection Between Gliomas, Neurodegenerative Diseases

Michigan Medicine - University of Michigan

New basic science and clinical research identifies TAU, the same protein studied in the development of Alzheimer’s, as a biomarker for glioma development.

Channels: Alzheimer's and Dementia, Cancer, Healthcare, Neuro, National Institutes of Health (NIH),

Released:
22-Jan-2020 7:20 PM EST
Open in New Tab
Comment
Expert Pitch
Embargo will expire:
24-Jan-2020 7:00 AM EST
Released to reporters:
22-Jan-2020 5:55 PM EST

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 24-Jan-2020 7:00 AM EST

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Expert Pitch
Embargo will expire:
4-Feb-2020 6:00 AM EST
Released to reporters:
22-Jan-2020 5:15 PM EST

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 4-Feb-2020 6:00 AM EST

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Research Results
NYUlogoLarge2597.png

Peer-Reviewed journal, Public Culture, Has New Home at NYU

New York University

Public Culture, the award winning interdisciplinary social sciences and humanities journal, has a new editorial home in the Steinhardt Department of Media, Culture and Communication (MCC) at New York University. Duke University Press will continue to oversee its print production.

Channels: In the Workplace, Media and Journalism, All Journal News,

Released:
22-Jan-2020 5:05 PM EST
Open in New Tab
Comment
Research Results

Social and Behavioral Sciences

mmc-logo.gif

Ciertas células hepáticas pueden prevenir rechazo del órgano después del trasplante y otras afecciones, descubre estudio

Mayo Clinic

Las células mesenquimales del estroma procedentes del tejido graso y de la médula ósea se emplean ampliamente en ensayos terapéuticos por sus cualidades antiinflamatorias, pero un nuevo estudio de Mayo Clinic descubre que las células hepáticas podrían ser más valiosas.

Channels: Autoimmune Diseases, Healthcare, Liver Disease, Transplantation, All Journal News,

Released:
22-Jan-2020 5:05 PM EST
Open in New Tab
Comment
Announcement
Embargo will expire:
24-Jan-2020 12:05 AM EST
Released to reporters:
22-Jan-2020 5:00 PM EST

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 24-Jan-2020 12:05 AM EST

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Research Results


0.48937